Baquiloprim
- Level
- Commodity
- Parent
- 51285200
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51285201This classification denotes an antiprotozoal agent with the molecular formula C17H20N6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3DE766VIG6, chemically known as 5-((2,4-diamino-5-pyrimidinyl)methyl)-8-(dimethylamino)-7-methylquinoline but more generally known as baquiloprim, which bears US NIH Compound Identifier 72121. European Medicines Agency schedules Baquiloprim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06100MIG. The term BAQUILOPRIM is an International Non-Proprietary Name. BAQUILOPRIM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.
Same parent
Under 51285200 · 6Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.